追加説明:
Filings include US-DMF, CEP, C-DMF, K-DMF, and CADIFA, under submission or approval. C2 Pharma supplies a broad range of active pharmaceutical ingredients and complex chemical compounds from synthetic and natural sources, including brimonidine tartrate. As a 0.2% ophthalmic solution, brimonidine lowers intraocular pressure through a dual mechanism - reducing aqueous humour production by the ciliary body and increasing uveoscleral outflow - while, applied topically as a 0.33% gel, it treats persistent (non-transient) erythema associated with rosacea.
評価とコメントを残す